Patents by Inventor Jörg Feesche

Jörg Feesche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9394528
    Abstract: The present invention relates to 25 hitherto undescribed genes of B. licheniformis and gene products derived therefrom and all sufficiently homologous nucleic acids and proteins thereof. They occur in five different metabolic pathways for the formation of odorous substances. The metabolic pathways in question are for the synthesis of: 1) isovalerian acid (as part of the catabolism of leucine), 2) 2-methylbutyric acid and/or isobutyric acid (as part of the catabolism of valine and/or isoleucine), 3) butanol and/or butyric acid (as part of the metabolism of butyric acid), 4) propyl acid (as part of the metabolism of propionate) and/or 5) cadaverine and/or putrescine (as parts of the catabolism of lysine and/or arginine).
    Type: Grant
    Filed: December 27, 2006
    Date of Patent: July 19, 2016
    Assignee: BASF SE
    Inventors: Cornelius Bessler, Jörg Feesche, Stefan Evers, Karl-Heinz Maurer, Armin Ehrenreich, Birgit Veith, Heiko Liesegang, Anke Henne, Christina Herzberg, Gerhard Gottschalk
  • Patent number: 7807443
    Abstract: The invention relates to five or four novel genes and the gene products thereof from Bacillus licheniformis and sufficiently similar genes and proteins which are involved in vivo in the formation of polyamino acids. The gene in question is ywsC, ywsC?, ywtA, ywtB and ywtD or proteins coded thereby. The gene ywsC, ywsC?, ywtA and ywtB can be used to improve biotechnological production methods by microorganisms, wherein they are functionally inactivated; the gene ywtD which codes for a peptide decomposing poly-gamma glutamate can, inversely, contribute to the improvement of biotechnological production methods by increased expression. Said genes can be used positively, preferably to result in a modification or decomposition of poly-gamma glutamate.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: October 5, 2010
    Assignee: Henkel AG & Co. KGaA
    Inventors: Jörg Feesche, Cornelius Bessler, Stefan Evers, Karl-Heinz Maurer, Armin Ehrenreich, Birgit Veith, Heiko Liesegang, Anke Henne, Christina Herzberg, Gerhard Gottschalk
  • Publication number: 20060040279
    Abstract: The present invention provides methods for determining the physiological state of cells isolated from an organism of interest utilizing chips to which nucleic acid probes are attached. In preferred embodiments of the invention, the cells undergo a biological process and the physiological state of the cells is determined at various points in time throughout the biological process.
    Type: Application
    Filed: March 11, 2005
    Publication date: February 23, 2006
    Applicant: Henkel Kommanditgesellschaft auf Aktien
    Inventors: Joerg Feesche, Karl-Heinz Maurer, Roland Breves, Thomas Schweder, Michael Hecker, Britta Juergen, Birgit Voigt